Header cover image

Danish (OMX) Biotech Industry Analysis

UpdatedMar 25, 2023
DataAggregated Company Financials
Companies5
  • 7D2.4%
  • 3M-13.0%
  • 1Y12.7%
  • YTD-13.2%

The Biotech industry is up 2.4% in the last week, with Genmab up 2.5%. During this same period, the BioPorto underperformed, falling 6.8%. In the last 12 months, the industry was up 13%. Earnings are forecast to grow by 19% annually.

Industry Valuation and Performance

Has the Danish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 26 Mar 2023kr.194.8bkr.17.9bkr.3.5b30.5x55x10.9x
Tue, 21 Feb 2023kr.210.1bkr.14.7bkr.3.3b32x64.2x14.3x
Thu, 19 Jan 2023kr.209.3bkr.14.7bkr.3.3b31.7x64x14.2x
Sat, 17 Dec 2022kr.225.3bkr.14.7bkr.3.3b35.3x68.8x15.3x
Mon, 14 Nov 2022kr.223.3bkr.14.7bkr.3.5b34.6x64.4x15.2x
Wed, 12 Oct 2022kr.201.9bkr.12.4bkr.1.5b44.8x132.9x16.3x
Fri, 09 Sep 2022kr.204.7bkr.12.4bkr.1.5b45.5x137.5x16.5x
Sun, 07 Aug 2022kr.201.3bkr.11.1bkr.130.5m70.3x1543x18.2x
Tue, 05 Jul 2022kr.175.8bkr.11.1bkr.130.5m64.7x1347.3x15.9x
Thu, 02 Jun 2022kr.154.6bkr.11.0b-kr.88,588,000.0057.4x-1745.6x14x
Sat, 30 Apr 2022kr.177.5bkr.10.7bkr.622.4m54.5x285.2x16.6x
Mon, 28 Mar 2022kr.171.3bkr.10.7bkr.625.7m51.7x273.7x16x
Wed, 23 Feb 2022kr.150.9bkr.10.4bkr.252.9m44.7x596.6x14.5x
Fri, 21 Jan 2022kr.173.9bkr.9.8bkr.117.9m52.7x1474.6x17.7x
Sun, 19 Dec 2021kr.187.5bkr.9.8bkr.117.9m56.2x1590.1x19.1x
Tue, 16 Nov 2021kr.205.7bkr.9.8bkr.112.0m61.7x1837.3x20.9x
Thu, 14 Oct 2021kr.215.2bkr.9.3b-kr.169,922,000.0073.1x-1266.4x23.1x
Sat, 11 Sep 2021kr.214.7bkr.9.3b-kr.169,922,000.0072.4x-1263.6x23.1x
Mon, 09 Aug 2021kr.217.5bkr.9.3b-kr.169,922,000.0075.4x-1279.8x23.4x
Sun, 02 May 2021kr.178.6bkr.13.2bkr.3.5b26.6x50.9x13.5x
Wed, 03 Feb 2021kr.185.1bkr.12.3bkr.3.5b39.9x53x15x
Sat, 07 Nov 2020kr.160.5bkr.13.3bkr.5.0b20.5x32.1x12.1x
Fri, 31 Jul 2020kr.164.2bkr.12.1bkr.5.1b24.3x32.2x13.5x
Mon, 04 May 2020kr.128.0bkr.6.6bkr.1.6b40.1x82.2x19.3x
Price to Earnings Ratio

69.1x


Total Market Cap: kr.107.6bTotal Earnings: kr.1.6bTotal Revenue: kr.6.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Biotech Industry Price to Earnings3Y Average 81.1x202120222023
Current Industry PE
  • Investors are pessimistic on the Danish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 55.0x which is lower than its 3-year average PE of 81.1x.
  • The 3-year average PS ratio of 16.4x is higher than the industry's current PS ratio of 10.9x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have grown 32% per year over the last three years.
  • Revenues for these companies have grown 39% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare industry?

DK Market3.72%
Healthcare6.10%
Biotech2.37%
Biotech2.37%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GMAB Genmabkr.2.58k2.5%
+kr.4.1b		8.6%PE30.5x
BAVA Bavarian Nordickr.182.502.5%
+kr.342.0m		14.1%PS4.5x
ZEAL Zealand Pharmakr.227.800.3%
+kr.31.0m		145.5%PS113.3x
ORPHA Orphazymekr.0.820.1%
+kr.35.3k		-85.6%PS0.8x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate Program
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

GMAB

kr.2,578.00

Genmab

7D

2.5%

1Y

8.6%

With EPS Growth And More, Genmab (CPH:GMAB) Makes An Interesting Case

Mar 18
With EPS Growth And More, Genmab (CPH:GMAB) Makes An Interesting Case

BAVA

kr.182.50

Bavarian Nordic

7D

2.5%

1Y

14.1%

BIOPOR

kr.1.77

BioPorto

7D

-6.8%

1Y

12.6%

We're Hopeful That BioPorto (CPH:BIOPOR) Will Use Its Cash Wisely

Feb 27
We're Hopeful That BioPorto (CPH:BIOPOR) Will Use Its Cash Wisely

ORPHA

kr.0.82

Orphazyme

7D

0.1%

1Y

-85.6%

ZEAL

kr.227.80

Zealand Pharma

7D

0.3%

1Y

145.5%